Autophagy potentiates the anti-cancer effects of the histone deacetylase inhibitors in hepatocellular carcinoma

Hepatocellular carcinoma (HCC) is the fifth most common cancer and the third leading cause of cancer death worldwide. Drug treatments for HCC have been largely unsuccessful. Histone deacetylase inhibitors can reactivate tumor suppressor genes in cancer cells and serve as potential anti-cancer drugs. Two potent HDAC inhibitors OSU-HDAC42 and SAHA induced autophagy in HCC cells as revealed by transmission electron microscopy, immunofluorescence and LC3-II accumulation. We found that SAHA and OSU-HDAC42 induced autophagy through downregulation of Akt/mTOR signaling and induction of ER stress response. Inhibition of autophagy by 3-MA or Atg5 knockout reduced SAHA-induced cytotoxicity, indicating that SAHA-induced autophagy led to cell death. Our results show that the combination of autophagy inducers with SAHA might be attractive for the treatment of HCC and pharmacological targeting of autophagy provides promise for the management of cancer therapy.

[1]  S. Barth,et al.  Autophagy: assays and artifacts , 2010, The Journal of pathology.

[2]  S. Qiu,et al.  Association of autophagy defect with a malignant phenotype and poor prognosis of hepatocellular carcinoma. , 2008, Cancer research.

[3]  M. Kudo.  Hepatocellular Carcinoma 2009 and Beyond: from the Surveillance to Molecular Targeted Therapy , 2008, Oncology.

[4]  T. Vanhaecke,et al.  Trichostatin A induces differential cell cycle arrests but does not induce apoptosis in primary cultures of mitogen-stimulated rat hepatocytes. , 2003, Journal of hepatology.

[5]  H. Kim,et al.  Expression of Fas-related genes in human hepatocellular carcinomas. , 1998, Cancer letters.

[6]  Ming-Shiang Wu,et al.  Inhibition of autophagy enhances anticancer effects of atorvastatin in digestive malignancies. , 2010, Cancer research.

[7]  S. Kulp,et al.  Efficacy of a novel histone deacetylase inhibitor in murine models of hepatocellular carcinoma , 2007, Hepatology.

[8]  T. Ueno,et al.  LC3 conjugation system in mammalian autophagy , 2004, The International Journal of Biochemistry & Cell Biology.

[9]  Anne Bertolotti,et al.  Dynamic interaction of BiP and ER stress transducers in the unfolded-protein response , 2000, Nature Cell Biology.

[10]  D. Rubinsztein,et al.  Potential therapeutic applications of autophagy , 2007, Nature Reviews Drug Discovery.

[11]  Jung-Hsin Lin,et al.  Statins increase p21 through inhibition of histone deacetylase activity and release of promoter-associated HDAC1/2. , 2008, Cancer research.

[12]  G. Gores,et al.  Hepatocellular carcinoma: molecular pathways and new therapeutic targets. , 2005, Seminars in liver disease.

[13]  Daniel J Klionsky,et al.  A unified nomenclature for yeast autophagy-related genes. , 2003, Developmental cell.

[14]  Z. Elazar,et al.  The N-terminus and Phe52 residue of LC3 recruit p62/SQSTM1 into autophagosomes , 2008, Journal of Cell Science.

[15]  P. Walter,et al.  Signal integration in the endoplasmic reticulum unfolded protein response , 2007, Nature Reviews Molecular Cell Biology.

[16]  R. Kaufman,et al.  From acute ER stress to physiological roles of the Unfolded Protein Response , 2006, Cell Death and Differentiation.

[17]  D. Schuppan,et al.  The histone-deacetylase inhibitor Trichostatin A blocks proliferation and triggers apoptotic programs in hepatoma cells. , 2002, Journal of hepatology.

[18]  M. Jäättelä,et al.  Connecting endoplasmic reticulum stress to autophagy by unfolded protein response and calcium , 2007, Cell Death and Differentiation.

[19]  P. Marks,et al.  Apoptotic and autophagic cell death induced by histone deacetylase inhibitors , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[20]  P. Dubbelhuis,et al.  Amino acid signalling and the integration of metabolism. , 2004, Biochemical and biophysical research communications.

[21]  W. Bursch,et al.  Active cell death induced by the anti-estrogens tamoxifen and ICI 164 384 in human mammary carcinoma cells (MCF-7) in culture: the role of autophagy. , 1996, Carcinogenesis.

[22]  T. Asano,et al.  Distinct Roles of Autophagy in the Heart During Ischemia and Reperfusion: Roles of AMP-Activated Protein Kinase and Beclin 1 in Mediating Autophagy , 2007, Circulation research.

[23]  A. Yamamoto,et al.  SKD1 AAA ATPase-dependent endosomal transport is involved in autolysosome formation. , 2002, Cell structure and function.

[24]  Daniel J Klionsky,et al.  Endoplasmic Reticulum Stress Triggers Autophagy* , 2006, Journal of Biological Chemistry.

[25]  S. Toyokuni,et al.  Induction of autophagy in malignant rhabdoid tumor cells by the histone deacetylase inhibitor FK228 through AIF translocation , 2009, International journal of cancer.

[26]  Terje Johansen,et al.  p62/SQSTM1 forms protein aggregates degraded by autophagy and has a protective effect on huntingtin-induced cell death , 2005, The Journal of cell biology.

[27]  T. Ekström,et al.  Apoptosis and tumor remission in liver tumor xenografts by 4-phenylbutyrate. , 2003, International journal of oncology.

[28]  L. Cantley,et al.  United at last: the tuberous sclerosis complex gene products connect the phosphoinositide 3-kinase/Akt pathway to mammalian target of rapamycin (mTOR) signalling. , 2003, Biochemical Society transactions.

[29]  John L Cleveland,et al.  Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes , 2008, Autophagy.

[30]  P. Tofilon,et al.  Activation of the unfolded protein response contributes toward the antitumor activity of vorinostat. , 2010, Neoplasia.

[31]  B. Levine,et al.  Cell biology: Autophagy and cancer , 2007, Nature.

[32]  H. Hibshoosh,et al.  Induction of autophagy and inhibition of tumorigenesis by beclin 1 , 1999, Nature.

[33]  K. W. Kim,et al.  Inhibition of mammalian target of rapamycin or apoptotic pathway induces autophagy and radiosensitizes PTEN null prostate cancer cells. , 2006, Cancer research.

[34]  T. Noda,et al.  Monitoring autophagy in mammalian cultured cells through the dynamics of LC3. , 2009, Methods in enzymology.

[35]  Y. Atomi,et al.  Autophagy is activated in colorectal cancer cells and contributes to the tolerance to nutrient deprivation. , 2007, Cancer research.

[36]  K. Inoki,et al.  TSC2 Mediates Cellular Energy Response to Control Cell Growth and Survival , 2003, Cell.

[37]  Gyan Bhanot,et al.  Autophagy Suppresses Tumorigenesis through Elimination of p62 , 2009, Cell.

[38]  W. Bursch,et al.  Programmed Cell Death (PCD): Apoptosis, Autophagic PCD, or Others? , 2000, Annals of the New York Academy of Sciences.

[39]  Jacques Ferlay,et al.  Estimating the world cancer burden: Globocan 2000 , 2001, International journal of cancer.

[40]  M. Minemura,et al.  Sodium butyrate enhances Fas-mediated apoptosis of human hepatoma cells. , 2004, Journal of hepatology.

[41]  S. Paggi,et al.  Sorafenib in Advanced Hepatocellular Carcinoma , 2008 .

[42]  Takeshi Noda,et al.  LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing , 2000, The EMBO journal.

[43]  Z. Wang,et al.  ER stress negatively regulates AKT/TSC/mTOR pathway to enhance autophagy , 2010, Autophagy.

[44]  K. Shiraki,et al.  Cellular FLICE/Caspase-8–Inhibitory Protein as a Principal Regulator of Cell Death and Survival in Human Hepatocellular Carcinoma , 2003, Laboratory Investigation.

[45]  Randal J. Kaufman,et al.  From endoplasmic-reticulum stress to the inflammatory response , 2008, Nature.

[46]  N. Mizushima,et al.  How to Interpret LC3 Immunoblotting , 2007, Autophagy.

[47]  M. Diaz-Meco,et al.  Signal integration and diversification through the p62 scaffold protein. , 2007, Trends in biochemical sciences.

[48]  Govind Bhagat,et al.  Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene. , 2003, The Journal of clinical investigation.